Web7 Jan 2024 · We are excited to be able to complete our highly ambitious medical program with the start of TAILORED-AF, a new randomized controlled trial (RCT),” Volta Medical … Web2 Mar 2024 · The VITAL-AF trial failed to show that atrial fibrillation screening resulted in a higher prevalence of newly diagnosed atrial fibrillation. Description: The goal of the trial …
VOLTA MEDICAL raises 28 million USD to revolutionize persistent …
Web31 Aug 2024 · Based on these encouraging results, Volta Medical has initiated the TAILORED-AF trial, the first randomized controlled clinical trial to evaluate VX1-guided … Web21 Sep 2024 · The Tailored-AF trial will take about two years to complete and is an international, multi-center, randomized, double-blind trial. About Rhode Island Hospital … jesus said the two great commandments
Mortality, stroke, and heart failure in atrial fibrillation cohorts af ...
Web12 Apr 2024 · The landmark PROTECT-AF trial showed that left atrial appendage occlusion was non-inferior to warfarin for preventing the combined outcome of stroke, systemic embolism, and cardiovascular death (hazard ratio 0.40, 95 ... The choice of a specific anti-arrhythmic drug is tailored to the individual patient on the basis of their atrial fibrillation ... Web6 Apr 2024 · An Expression of Interest (EOI) to Develop an End-to-End Low or Zero-Carbon Ammonia Power Generation and Bunkering Solution in Singapore was put out in February 2024. Global trends such as ... Web2 Feb 2024 · TAILORED-AF is an international, multicenter trial designed to determine if a tailored VX1 AI software-guided ablation strategy targeting areas of spatiotemporal dispersion in combination with pulmonary vein isolation (PVI) is superior to a conventional anatomical ablation strategy targeting PVI alone for the treatment of persistent AF. jesus said the two greatest commandments are